Caption Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Caption Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-175,600	Closed	-$3.08M	–	2103
2021 Q3	$3.08M	Buy	+175,600	New	+$2.05M	0.04%	608
2020 Q4	–	Sell	-15,000	Closed	-$214K	–	1335
2020 Q3	$214K	Sell	15,000 -85,000	-85%	-$847K	0.01%	904
2020 Q2	$809K	Buy	+100,000	New	+$619K	0.03%	581

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Caption Management's TRIL Position: Q1 2021 in Review

Caption Management sold out of Trillium Therapeutics Inc. (TRIL) in Q1 2021, closing a stake of 75,000 shares — an estimated $1.1M sold.

Caption Management first reported a position in TRIL in Q4 2020 and held it in 1 quarter. The position peaked at $1.1M in Q4 2020. 125 funds tracked by Wall St. Rank hold TRIL as of Q1 2021.

Caption Management reported no remaining Trillium Therapeutics Inc. position as of Q1 2021 after selling out during the quarter.
Caption Management sold 75,000 Trillium Therapeutics Inc. shares in Q1 2021, an estimated $1.1M.
Caption Management first reported a position in Trillium Therapeutics Inc. in Q4 2020 and held it in 1 quarter.
Caption Management's Trillium Therapeutics Inc. position peaked at $1.1M in Q4 2020.
125 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q1 2021.

Based on Caption Management's 13F filing for Q1 2021, filed 17 May 2021.